300804 广康生化
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-0.0423.0272.6593.17717.221
总资产报酬率 ROA (%)-0.0261.9371.8172.17411.335
投入资产回报率 ROIC (%)-0.0302.2462.0292.36112.839

边际利润分析
销售毛利率 (%)19.18224.14420.75624.03029.281
营业利润率 (%)-0.6536.2564.0756.28616.105
息税前利润/营业总收入 (%)2.0358.0736.2047.75215.753
净利润/营业总收入 (%)-0.2395.3554.7336.07514.574

收益指标分析
经营活动净收益/利润总额(%)129.24098.03064.68795.130103.847
价值变动净收益/利润总额(%)-78.07415.63328.00313.2710.000
营业外收支净额/利润总额(%)38.755-10.89014.690-1.657-2.663

偿债能力分析
流动比率 (X)1.8771.7102.0392.0401.282
速动比率 (X)1.3911.3631.7531.7210.890
资产负债率 (%)36.42738.29833.32929.78935.101
带息债务/全部投入资本 (%)27.03527.47020.75324.14924.911
股东权益/带息债务 (%)264.723259.166373.771310.606292.624
股东权益/负债合计 (%)174.402161.016199.875235.690184.890
利息保障倍数 (X)0.6563.3214.3484.943239.800

营运能力分析
应收账款周转天数 (天)95.41384.93281.727100.65161.728
存货周转天数 (天)162.179116.39595.970118.40381.800